Professional Documents
Culture Documents
1
Presentation Facts
0021003 2
Acknowledgments
This is a presentation of the
American Academy of Family Physicians
supported by an educational grant from
Aventis Pharmaceuticals
0021003 3
Acknowledgments
and
0021003 4
Upon Completion of This Presentation
You Should be Able To
0021003 5
Chronic Idiopathic Urticaria (CIU)
• Consists of hives
0021003 6
Hives – Lesions That Are:
• Pruritic
• Erythematous
• Roughly circular
• Sometimes confluent
0021003 7
Photo Images of Hives
0021003 8
Photo Images of Hives
0021003 9
Photo Images of Hives
0021003 10
Photo Images of Hives
0021003 11
Photo Images of Hives
0021003 12
Prevalence
0021003 13
Remission and Recurrence
0021003 15
Angioedema
0021003 16
Photo Image of Angioedema of Face
0021003 17
Urticaria/Angioedema
0021003 18
Differential Diagnoses
0021003 19
Eliciting Physical Urticarias
Selected Procedures
0021003 20
Duration of Symptoms
0021003 21
Urticaria: What Can Make it Worse?
• Anxiety
0021003 22
Autoimmune Association
0021003 23
Evaluation
0021003 24
Therapeutic Options
• H1 receptor antagonists
• Leukotriene antagonists
• Sympathomimetic agents
• Corticosteroids
• Experimental therapies
0021003 25
Histamine H1- Receptor Antagonists
0021003 26
New Generation Antihistamines
Recommended Doses in CIU*
** 2-5 years
† 6 months-11 years
‡ 6-11 years
* Respective package inserts
0021003 27
Combined H1-H2 Receptor Antagonists
0021003 28
Leukotriene Antagonists
0021003 29
Sympathomimetic Agents
• Efficacy low
0021003 30
Corticosteroids
0021003 31
Experimental Therapies
0021003 32
Recommendations
0021003 33
Thank You
0021003 34